Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of Domperidone in RRMS
NCT02493049Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Aug 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of domperidone in relapsing-remitting multiple sclerosis (RRMS), sponsored by University of Calgary. Started Aug 2015; status: completed.
02
Drugs
domperidone
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT02493049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493049.